Hudson Bay Capital Management LP Clearside Biomedical, Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 18,411 shares of CLSD stock, worth $16,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,411Holding current value
$16,201% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.47 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.93 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$1.33 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$702,3600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$697,1770.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $53M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...